Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit

Journal of Neurology
Gabriele ArendtH J Freund


Motor tests were performed in 50 HIV-infected patients in all stages according to the current CDC classification, but without any clinically evident central nervous system deficit, and the results compared with an age-matched control group. Patients were excluded from the study if there was alcohol or drug abuse, fever and/or opportunistic cerebral infection. The parameters tested were postural tremor of the outstretched hands, most rapid voluntary alternating index finger movements (MRAM) and rise time of most rapid index finger extensions (MRC). Whereas tremor peak frequencies did not differ significantly in the patients and controls, MRAM and rise times of MRCs showed significant slowing in the patient group. Morphologically, the motor test performance of the HIV-infected patients was similar to that of patients with manifest basal ganglia disease (Parkinson's, Huntington's and Wilson's diseases). MRI scans of all patients were normal. It is concluded that in HIV-infected patients there is a very early subclinical central nervous system affection, especially of the basal ganglia, which is detectable with appropriate, quantitative motor function tests. These functional abnormalities precede the structural alterations in the M...Continue Reading


May 1, 1978·Journal of Neurophysiology·J H AllumH J Freund
Jun 1, 1986·Electroencephalography and Clinical Neurophysiology·V HömbergM Hennerici
Mar 1, 1988·Reviews of Infectious Diseases·G A Elder, J L Sever
Oct 1, 1986·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·J C McArthur, J C McArthur
Jun 1, 1987·Brain : a Journal of Neurology·H HefterH J Freund
Aug 1, 1985·Human Pathology·L R SharerL G Epstein
Nov 1, 1985·Annals of Internal Medicine·L Montagnier
May 30, 1986·Science·D M Barnes
Jul 11, 1986·Science·S GartnerM Popovic
Jun 1, 1986·Annals of Neurology·B A NaviaR W Price
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C A WileyM B Oldstone
Dec 15, 1988·The New England Journal of Medicine·F A SchmittJ L Drucker
Mar 27, 1987·Science·D M Barnes
May 1, 1987·Annals of Neurology·T Pumarola-SuneR W Price
Dec 1, 1987·American Family Physician·D B Clifford
Jun 1, 1986·Annals of Neurology·B A NaviaR W Price
Jan 1, 1987·Neurology·A NathL C Pettigrew
Sep 1, 1985·Brain : a Journal of Neurology·H J Freund, H Hummelsheim
Apr 1, 1986·Biological Psychiatry·T P BeresfordR C Hall
Sep 1, 1967·Journal of Applied Physiology·R N Stiles, J E Randall
Mar 1, 1981·Brain : a Journal of Neurology·E V EvartsD B Calne


Dec 1, 1991·Journal of Neurology·Gabriele ArendtH J Freund
Sep 1, 1993·Journal of Neurology·P PetiotG Aimard
Dec 1, 1994·Journal of Neurology·H-J von GiesenGabriele Arendt
May 23, 2009·Neuropsychology Review·Steven Paul WoodsIgor Grant
Feb 5, 2004·Current Treatment Options in Neurology·A Nath, J R Berger
Mar 1, 1993·Electroencephalography and Clinical Neurophysiology·Gabriele ArendtH Jablonowski
Nov 1, 1993·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·T BaldewegJ Catalan
Dec 31, 2003·Neurotoxicology·E KoutsilieriPeter Riederer
Sep 1, 1992·Acta Neurologica Scandinavica·N R KarlsenS S Frøland
Sep 4, 1999·Journal of Medical Primatology·J K MarcarioP D Cheney
Oct 9, 2014·Der Nervenarzt·C Eggers, für die Deutsche Neuro-AIDS-Arbeitsgemeinschaft (DNAA)
Oct 1, 2013·Journal of Neurovirology·Mario OrtegaBeau M Ances
Mar 6, 2008·Neuroimaging Clinics of North America·Majda M Thurnher, M Judith Donovan Post
Jul 21, 2004·Parkinsonism & Related Disorders·Winona TseWilliam Koller
Nov 25, 2003·HIV Clinical Trials·Hans Jürgen von GiesenGabriele Arendt
Jan 14, 2010·Arquivos de neuro-psiquiatria·Fidias E Leon-SarmientoNash N Boutros
Dec 6, 2000·Journal of Psychopharmacology·J R Berger, Gabriele Arendt
Jan 15, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Hans-Jürgen von GiesenGabriele Arendt
Aug 1, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·S M MirsattariA Nath
Mar 16, 2006·European Journal of Gastroenterology & Hepatology·Daniel M FortonHoward C Thomas
Mar 28, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Hans Jürgen von GiesenGabriele Arendt
May 16, 2017·Frontiers in Human Neuroscience·Sharif I KronemerCherie L Marvel
Feb 1, 1993·Acta Neurologica Scandinavica·N R KarlsenS S Frøland
Feb 1, 1993·Acta Neurologica Scandinavica·H HefterH J Freund
Sep 6, 2003·Acta Neurologica Scandinavica·H-J von GiesenH Hefter
Jun 2, 2017·Journal of Neurology·Christian EggersGerman Association of Neuro-AIDS und Neuro-Infectiology (DGNANI)
Jan 11, 2019·Journal of Neurovirology·Gabriele ArendtOlaf Stüve

Related Concepts

Lenticulostriate Disorders
Magnetization Transfer Contrast Imaging
Static Tremor
HIV Infections

Related Feeds

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.